July 16, 2021
Immupharma adds COO to the board of directors
ImmuPharma, the specialist drug discovery and development company, has appointed Dr Tim Franklin, Chief Operating Officer, to the Board of Directors.
Pharmaceuticals, Biotechnology and Life Sciences
Tag: ImmuPharma
June 28, 2019
ImmuPharma meets primary goal in additional Lupuzor study
ImmuPharma has met the primary endpoint in additional study, testing Lupuzor, after requests from Investigators and patients involved in the Pivotal Phase III study, permitting patients who participated in the Phase III study, to receive Lupuzor.
January 24, 2018
ImmuPharma cashes in £10M ($14.03M)
ImmuPharma has completed a fundraise totalling £10 million (14.03million) before expenses by placing 6,944,445 new ordinary shares of 10p each…
October 4, 2017
ImmuPharma, Lanstead Capital finish sharing deal, Phase III results for Lupuzor in Q1 2018
ImmuPharma has completed a sharing agreement with Lanstead Capital from February 2016, for supporting of ImmuPharma’s pivotal Phase III clinical trial…
June 30, 2017
ImmuPharma expects Lupus drug test top line results in 2018
ImmuPharma said Friday that 200 patients were recruited and dosed in its Phase III trial of Lupus drug Lupuzor. Furthermore, all 200 patients have passed the 3 months stage, with over 90% of patients (184) have passed 6 months.
January 25, 2017
ImmuPharma recruits patients for Lupus drug testing
ImmuPharma has provided details of patient recruitment into its pivotal 52-week Phase III clinical trial of Lupuzor, its lead programme for the potential breakthrough compound for Lupus.
January 24, 2017
ImmuPharma appoints new adviser
ImmuPharma has appointed Northland Capital Partners as its Nominated Adviser and sole broker with immediate effect. ImmuPharma is a pharmaceutical…
December 22, 2016
ImmuPharma recruits patients for Phase III study of Lupuzor
ImmuPharma has completed patients recruitment regarding pivotal Phase III clinical trial of Lupuzor, its lead programme for the potential breakthrough…
September 30, 2015
ImmuPharma:Tim McCarthy Appointed as Non-executive Chairman
ImmuPharma PLC the specialist drug discovery and development company, has announced the appointment of Tim McCarthy as Non-executive Chairman, with immediate effect.